Works matching AU Hortobagyi, Gabriel N.


Results: 340
    1
    2

    Neoadjuvant Chemotherapy.

    Published in:
    Breast Disease, 2004, v. 21, n. 1, p. 23, doi. 10.3233/BD-2004-21104
    By:
    • Green, Marjorie C.;
    • Esteva, Francisco J.;
    • Hortobagyi, Gabriel N.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

    Published in:
    2013
    By:
    • Pritchard, Kathleen I;
    • Burris 3rd, Howard A;
    • Ito, Yoshinori;
    • Rugo, Hope S;
    • Dakhil, Shaker;
    • Hortobagyi, Gabriel N;
    • Campone, Mario;
    • Csöszi, Tibor;
    • Baselga, José;
    • Puttawibul, Puttisak;
    • Piccart, Martine;
    • Heng, Daniel;
    • Noguchi, Shinzaburo;
    • Srimuninnimit, Vichien;
    • Bourgeois, Hugues;
    • Gonzalez Martin, Antonio;
    • Osborne, Karen;
    • Panneerselvam, Ashok;
    • Taran, Tetiana;
    • Sahmoud, Tarek
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19
    20
    21

    Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).

    Published in:
    Biomarkers, 2023, v. 28, n. 3, p. 313, doi. 10.1080/1354750X.2023.2168063
    By:
    • Bergqvist, Mattias;
    • Nordmark, Adrian;
    • Williams, Amy;
    • Paoletti, Costanza;
    • Barlow, William;
    • Cobain, Erin F.;
    • Mehta, Rita S.;
    • Gralow, Julie R.;
    • Hortobagyi, Gabriel N.;
    • Albain, Kathy S.;
    • Pusztai, Lajos;
    • Sharma, Priyanka;
    • Godwin, Andrew K.;
    • Thompson, Alastair M.;
    • Hayes, Daniel F.;
    • Rae, James M.
    Publication type:
    Article
    22
    23

    High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2<sup>+</sup> Inflammatory Breast Cancer.

    Published in:
    PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0083113
    By:
    • Anfossi, Simone;
    • Giordano, Antonio;
    • Gao, Hui;
    • Cohen, Evan N.;
    • Tin, Sanda;
    • Wu, Qiong;
    • Garza, Raul J.;
    • Debeb, Bisrat G.;
    • Alvarez, Ricardo H.;
    • Valero, Vicente;
    • Hortobagyi, Gabriel N.;
    • Calin, George A.;
    • Ueno, Naoto T.;
    • Woodward, Wendy A.;
    • Reuben, James M.
    Publication type:
    Article
    24
    25
    26
    27
    28

    Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 10, p. 1908, doi. 10.1002/cncr.28010
    By:
    • Burris, Howard A.;
    • Lebrun, Fabienne;
    • Rugo, Hope S.;
    • Beck, J. Thaddeus;
    • Piccart, Martine;
    • Neven, Patrick;
    • Baselga, Jose;
    • Petrakova, Katarina;
    • Hortobagyi, Gabriel N.;
    • Komorowski, Anna;
    • Chouinard, Edmond;
    • Young, Robyn;
    • Gnant, Michael;
    • Pritchard, Kathleen I.;
    • Bennett, Lee;
    • Ricci, Jean‐Francois;
    • Bauly, Hounayda;
    • Taran, Tetiana;
    • Sahmoud, Tarek;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    29
    30

    Male breast cancer according to tumor subtype and race.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 9, p. 1611, doi. 10.1002/cncr.27905
    By:
    • Chavez‐MacGregor, Mariana;
    • Clarke, Christina A.;
    • Lichtensztajn, Daphne;
    • Hortobagyi, Gabriel N.;
    • Giordano, Sharon H.
    Publication type:
    Article
    31

    Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.

    Published in:
    2013
    By:
    • Gonzalez-Angulo AM;
    • Chen H;
    • Karuturi MS;
    • Chavez-Macgregor M;
    • Tsavachidis S;
    • Meric-Bernstam F;
    • Do KA;
    • Hortobagyi GN;
    • Thompson PA;
    • Mills GB;
    • Bondy ML;
    • Blumenschein GR Jr;
    • Gonzalez-Angulo, Ana M;
    • Chen, Huiqin;
    • Karuturi, Meghan S;
    • Chavez-MacGregor, Mariana;
    • Tsavachidis, Spyrus;
    • Meric-Bernstam, Funda;
    • Do, Kim-Anh;
    • Hortobagyi, Gabriel N
    Publication type:
    journal article
    32

    Frequency of mesenchymal-epithelial transition factor gene ( MET) and the catalytic subunit of phosphoinositide-3-kinase ( PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 1, p. 7, doi. 10.1002/cncr.27608
    By:
    • Gonzalez‐Angulo, Ana M.;
    • Chen, Huiqin;
    • Karuturi, Meghan S.;
    • Chavez‐MacGregor, Mariana;
    • Tsavachidis, Spyrus;
    • Meric‐Bernstam, Funda;
    • Do, Kim‐Anh;
    • Hortobagyi, Gabriel N.;
    • Thompson, Patricia A.;
    • Mills, Gordon B.;
    • Bondy, Melissa L.;
    • Blumenschein, George R.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Predictive factors for BRCA1/ BRCA2 mutations in women with ductal carcinoma in situ.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 6, p. 1515, doi. 10.1002/cncr.26428
    By:
    • Bayraktar, Soley;
    • Elsayegh, Nisreen;
    • Gutierrez Barrera, Angelica M.;
    • Lin, Heather;
    • Kuerer, Henry;
    • Tasbas, Tunc;
    • Muse, Kimberly I.;
    • Ready, Kaylene;
    • Litton, Jennifer;
    • Meric-Bernstam, Funda;
    • Hortobagyi, Gabriel N.;
    • Albarracin, Constance T.;
    • Arun, Banu
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50